A growing number of studies suggested that adiponectin is decreased in obesity and negatively correlated to visceral fat mass, inflammation, heart disease, injury, and many other diseases but positively to insulin sensitivity and promotes weight loss [30–33]. Here, ADIPOQ is linked to obesity disorder.